acetylacetoin reductase (NADH)

Known as: AACR II 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
0500100019992018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Atezolizumab (Tecentriq, MPDL3280A; Genentech/Roche) is an FcγR binding-deficient, fully humanized IgG1 mAb designed to interfere… (More)
Is this relevant?
Review
2017
Review
2017
On April 25, 2016, the FDA approved cabozantinib (Cabometyx; Exelixis, Inc.) for the treatment of advanced renal cell carcinoma… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
Purpose: Patients with pancreatic neuroendocrine neoplasm grade-3 (PanNEN-G3) show variable responses to platinum-based… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2017
Review
2017
Humans consider themselves discrete autonomous organisms, but recent research is rapidly strengthening the appreciation that… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2016
Review
2016
The receptors CD96 and TIGIT are expressed on the surface of T and natural killer (NK) cells, and recent studies suggest both… (More)
Is this relevant?
Review
2016
Review
2016
Metabolite profiling is being increasing employed in the study of prostate cancer as a means of identifying predictive… (More)
Is this relevant?
Highly Cited
2016
Highly Cited
2016
PURPOSE Approximately one-third of patients with non-small cell lung cancer (NSCLC) harboring tumors with EGFR-tyrosine kinase… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2016
Highly Cited
2016
PURPOSE To identify baseline peripheral blood biomarkers associated with clinical outcome following ipilimumab treatment in… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Long noncoding RNAs (lncRNA) have been implicated in human cancer but their mechanisms of action are mainly undocumented. In this… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
One of several challenges in design of clinical chemoprevention trials is the selection of the dose, formulation, and dose… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?